BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Abstract
Authors
L. Scaccabarozzi E. Asano T.B. Guimarães
L. Scaccabarozzi E. Asano T.B. Guimarães
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now